Connection

Carol Feghali-Bostwick to Skin

This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Skin.
Connection Strength

4.222
  1. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Ann Rheum Dis. 2022 02; 81(2):268-277.
    View in: PubMed
    Score: 0.621
  2. Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5. Int J Mol Sci. 2020 Dec 30; 22(1).
    View in: PubMed
    Score: 0.585
  3. Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival. Arthritis Res Ther. 2019 04 02; 21(1):85.
    View in: PubMed
    Score: 0.518
  4. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis. PLoS One. 2014; 9(2):e87754.
    View in: PubMed
    Score: 0.363
  5. Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-. Nihon Rinsho Meneki Gakkai Kaishi. 2013; 36(6):452-8.
    View in: PubMed
    Score: 0.336
  6. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Arthritis Rheum. 2006 Sep; 54(9):3001-10.
    View in: PubMed
    Score: 0.217
  7. Reduced Cathepsin L expression and secretion into the extracellular milieu contribute to lung fibrosis in systemic sclerosis. Rheumatology (Oxford). 2023 03 01; 62(3):1306-1316.
    View in: PubMed
    Score: 0.170
  8. First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry. Int J Mol Sci. 2023 Feb 11; 24(4).
    View in: PubMed
    Score: 0.169
  9. PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1. Front Immunol. 2021; 12:745308.
    View in: PubMed
    Score: 0.156
  10. Elucidating the cellular mechanism for E2-induced dermal fibrosis. Arthritis Res Ther. 2021 02 27; 23(1):68.
    View in: PubMed
    Score: 0.148
  11. A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGF? Early Response Gene that Mediates Fibroblast to Myofibroblast Transition. Genes (Basel). 2019 01 22; 10(2).
    View in: PubMed
    Score: 0.128
  12. Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-? signaling. J Dermatol Sci. 2018 May; 90(2):199-208.
    View in: PubMed
    Score: 0.120
  13. Tenascin-C drives persistence of organ fibrosis. Nat Commun. 2016 06 03; 7:11703.
    View in: PubMed
    Score: 0.106
  14. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 2013 Jan; 65(1):236-46.
    View in: PubMed
    Score: 0.084
  15. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS One. 2012; 7(8):e43049.
    View in: PubMed
    Score: 0.082
  16. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol. 1992 Aug; 19(8):1207-11.
    View in: PubMed
    Score: 0.082
  17. A peptide derived from endostatin ameliorates organ fibrosis. Sci Transl Med. 2012 May 30; 4(136):136ra71.
    View in: PubMed
    Score: 0.081
  18. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum. 2011 Nov; 63(11):3563-74.
    View in: PubMed
    Score: 0.077
  19. Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index. PLoS One. 2020; 15(10):e0240986.
    View in: PubMed
    Score: 0.036
  20. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Ann Rheum Dis. 2020 04; 79(4):507-517.
    View in: PubMed
    Score: 0.034
  21. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum. 1999 Jul; 42(7):1451-7.
    View in: PubMed
    Score: 0.033
  22. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity. 1994; 17(4):309-18.
    View in: PubMed
    Score: 0.023
  23. Toll-like receptor 4 signaling augments transforming growth factor-? responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol. 2013 Jan; 182(1):192-205.
    View in: PubMed
    Score: 0.021
  24. PPAR? downregulation by TGF? in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One. 2010 Nov 02; 5(11):e13778.
    View in: PubMed
    Score: 0.018
  25. Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma. Am J Pathol. 2008 Oct; 173(4):1085-99.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.